|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
children
oral drops
|
|
gptkbp:alsoKnownAs
|
OPV
|
|
gptkbp:alternativeTo
|
gptkb:Inactivated_Poliovirus_Vaccine
|
|
gptkbp:cause
|
vaccine-derived poliovirus (rarely)
|
|
gptkbp:compatibleWith
|
United States (since 2000)
|
|
gptkbp:contains
|
live attenuated poliovirus
|
|
gptkbp:cost
|
low
|
|
gptkbp:developedBy
|
gptkb:Albert_Sabin
|
|
gptkbp:distribution
|
global
|
|
gptkbp:effect
|
high
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Oral Poliovirus Vaccine
|
|
gptkbp:includedIn
|
gptkb:Expanded_Programme_on_Immunization
|
|
gptkbp:introducedIn
|
1961
|
|
gptkbp:numberOfDoses
|
multiple
|
|
gptkbp:prevention
|
poliomyelitis
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
mild gastrointestinal symptoms
vaccine-associated paralytic poliomyelitis (very rare)
|
|
gptkbp:storage
|
refrigeration
|
|
gptkbp:target
|
poliomyelitis
|
|
gptkbp:type
|
bivalent
monovalent
trivalent
|
|
gptkbp:usedIn
|
low- and middle-income countries
global polio eradication campaigns
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:WHORecommended
|
true
|
|
gptkbp:bfsParent
|
gptkb:IPV
|
|
gptkbp:bfsLayer
|
7
|